Skip to main content
. 2014 Dec;66(Suppl 3):S1–S51. doi: 10.1016/j.ihj.2014.12.001

Fig. 3.

Fig. 3

Overall approach to lipid-lowering therapy for prevention of cardiovascular disease. (HDL-C- high-density lipoprotein cholesterol, LDL-C- low-density lipoprotein cholesterol). * Please note, non-HDL-C is an acceptable primary target of lipid lowering therapy if LDL-C values are not available or not reliable.